Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1998 Jul;63(1):71–79. doi: 10.1086/301920

A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype.

P Guldberg 1, F Rey 1, J Zschocke 1, V Romano 1, B François 1, L Michiels 1, K Ullrich 1, G F Hoffmann 1, P Burgard 1, H Schmidt 1, C Meli 1, E Riva 1, I Dianzani 1, A Ponzone 1, J Rey 1, F Güttler 1
PMCID: PMC1377241  PMID: 9634518

Abstract

Phenylketonuria (PKU) and mild hyperphenylalaninemia (MHP) are allelic disorders caused by mutations in the gene encoding phenylalanine hydroxylase (PAH). Previous studies have suggested that the highly variable metabolic phenotypes of PAH deficiency correlate with PAH genotypes. We identified both causative mutations in 686 patients from seven European centers. On the basis of the phenotypic characteristics of 297 functionally hemizygous patients, 105 of the mutations were assigned to one of four arbitrary phenotype categories. We proposed and tested a simple model for correlation between genotype and phenotypic outcome. The observed phenotype matched the predicted phenotype in 79% of the cases, and in only 5 of 184 patients was the observed phenotype more than one category away from that expected. Among the seven contributing centers, the proportion of patients for whom the observed phenotype did not match the predicted phenotype was 4%-23% (P<.0001), suggesting that differences in methods used for mutation detection or phenotype classification may account for a considerable proportion of genotype-phenotype inconsistencies. Our data indicate that the PAH-mutation genotype is the main determinant of metabolic phenotype in most patients with PAH deficiency. In the present study, the classification of 105 PAH mutations may allow the prediction of the biochemical phenotype in >10,000 genotypes, which may be useful for the management of hyperphenylalaninemia in newborns.

Full Text

The Full Text of this article is available as a PDF (457.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antonarakis S. E. Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum Mutat. 1998;11(1):1–3. doi: 10.1002/(SICI)1098-1004(1998)11:1<1::AID-HUMU1>3.0.CO;2-O. [DOI] [PubMed] [Google Scholar]
  2. Burgard P., Rupp A., Konecki D. S., Trefz F. K., Schmidt H., Lichter-Konecki U. Phenylalanine hydroxylase genotypes, predicted residual enzyme activity and phenotypic parameters of diagnosis and treatment of phenylketonuria. Eur J Pediatr. 1996 Jul;155 (Suppl 1):S11–S15. doi: 10.1007/pl00014222. [DOI] [PubMed] [Google Scholar]
  3. Cuppens H., Cassiman J. J. A quality control study of CFTR mutation screening in 40 different European laboratories. The European Concerted Action on Cystic Fibrosis. Eur J Hum Genet. 1995;3(4):235–245. doi: 10.1159/000472304. [DOI] [PubMed] [Google Scholar]
  4. Desviat L. R., Pérez B., De Lucca M., Cornejo V., Schmidt B., Ugarte M. Evidence in Latin America of recurrence of V388M, a phenylketonuria mutation with high in vitro residual activity. Am J Hum Genet. 1995 Aug;57(2):337–342. [PMC free article] [PubMed] [Google Scholar]
  5. Desviat L. R., Pérez B., García M. J., Martínez-Pardo M., Baldellou A., Arena J., Sanjurjo P., Campistol J., Couce M. L., Fernández A. Relationship between mutation genotype and biochemical phenotype in a heterogeneous Spanish phenylketonuria population. Eur J Hum Genet. 1997 Jul-Aug;5(4):196–202. [PubMed] [Google Scholar]
  6. Desviat L. R., Pérez B., Ugarte M. Molecular basis of non-PKU hyperphenylalaninaemia in Spain: prevalence of A403V, a mutation with high residual activity. J Inherit Metab Dis. 1996;19(2):227–230. doi: 10.1007/BF01799436. [DOI] [PubMed] [Google Scholar]
  7. Dianzani I., Giannattasio S., de Sanctis L., Alliaudi C., Lattanzio P., Dionisi Vici C., Burlina A., Burroni M., Sebastio G., Carnevale F. Characterization of phenylketonuria alleles in the Italian population. Eur J Hum Genet. 1995;3(5):294–302. doi: 10.1159/000472313. [DOI] [PubMed] [Google Scholar]
  8. Eiken H. G., Knappskog P. M., Apold J., Flatmark T. PKU mutation G46S is associated with increased aggregation and degradation of the phenylalanine hydroxylase enzyme. Hum Mutat. 1996;7(3):228–238. doi: 10.1002/(SICI)1098-1004(1996)7:3<228::AID-HUMU7>3.0.CO;2-6. [DOI] [PubMed] [Google Scholar]
  9. Eiken H. G., Knappskog P. M., Motzfeldt K., Boman H., Apold J. Phenylketonuria genotypes correlated to metabolic phenotype groups in Norway. Eur J Pediatr. 1996 Jul;155(7):554–560. doi: 10.1007/BF01957904. [DOI] [PubMed] [Google Scholar]
  10. Eisensmith R. C., Martinez D. R., Kuzmin A. I., Goltsov A. A., Brown A., Singh R., Elsas LJ I. I., Woo S. L. Molecular basis of phenylketonuria and a correlation between genotype and phenotype in a heterogeneous southeastern US population. Pediatrics. 1996 Apr;97(4):512–516. [PubMed] [Google Scholar]
  11. Eisensmith R. C., Woo S. L. Molecular basis of phenylketonuria and related hyperphenylalaninemias: mutations and polymorphisms in the human phenylalanine hydroxylase gene. Hum Mutat. 1992;1(1):13–23. doi: 10.1002/humu.1380010104. [DOI] [PubMed] [Google Scholar]
  12. Guldberg P., Henriksen K. F., Thöny B., Blau N., Güttler F. Molecular heterogeneity of nonphenylketonuria hyperphenylalaninemia in 25 Danish patients. Genomics. 1994 May 15;21(2):453–455. doi: 10.1006/geno.1994.1296. [DOI] [PubMed] [Google Scholar]
  13. Guldberg P., Levy H. L., Henriksen K. F., Guttler F. Three prevalent mutations in a patient with phenylalanine hydroxylase deficiency: implications for diagnosis and genetic counselling. J Med Genet. 1996 Feb;33(2):161–164. doi: 10.1136/jmg.33.2.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Guldberg P., Levy H. L., Koch R., Berlin C. M., Jr, Francois B., Henriksen K. F., Güttler F. Mutation analysis in families with discordant phenotypes of phenylalanine hydroxylase deficiency. Inheritance and expression of the hyperphenylalaninaemias. J Inherit Metab Dis. 1994;17(6):645–651. doi: 10.1007/BF00712004. [DOI] [PubMed] [Google Scholar]
  15. Guldberg P., Mikkelsen I., Henriksen K. F., Lou H. C., Güttler F. In vivo assessment of mutations in the phenylalanine hydroxylase gene by phenylalanine loading: characterization of seven common mutations. Eur J Pediatr. 1995 Jul;154(7):551–556. doi: 10.1007/BF02074833. [DOI] [PubMed] [Google Scholar]
  16. Güttler F., Guldberg P. The influence of mutations of enzyme activity and phenylalanine tolerance in phenylalanine hydroxylase deficiency. Eur J Pediatr. 1996 Jul;155 (Suppl 1):S6–10. doi: 10.1007/pl00014253. [DOI] [PubMed] [Google Scholar]
  17. Güttler F. Hyperphenylalaninemia: diagnosis and classification of the various types of phenylalanine hydroxylase deficiency in childhood. Acta Paediatr Scand Suppl. 1980;280:1–80. [PubMed] [Google Scholar]
  18. Hufton S. E., Jennings I. G., Cotton R. G. Structure and function of the aromatic amino acid hydroxylases. Biochem J. 1995 Oct 15;311(Pt 2):353–366. doi: 10.1042/bj3110353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. John S. W., Scriver C. R., Laframboise R., Rozen R. In vitro and in vivo correlations for I65T and M1V mutations at the phenylalanine hydroxylase locus. Hum Mutat. 1992;1(2):147–153. doi: 10.1002/humu.1380010210. [DOI] [PubMed] [Google Scholar]
  20. Kayaalp E., Treacy E., Waters P. J., Byck S., Nowacki P., Scriver C. R. Human phenylalanine hydroxylase mutations and hyperphenylalaninemia phenotypes: a metanalysis of genotype-phenotype correlations. Am J Hum Genet. 1997 Dec;61(6):1309–1317. doi: 10.1086/301638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Krawczak M., Reiss J., Cooper D. N. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet. 1992 Sep-Oct;90(1-2):41–54. doi: 10.1007/BF00210743. [DOI] [PubMed] [Google Scholar]
  22. Ledley F. D., Levy H. L., Woo S. L. Molecular analysis of the inheritance of phenylketonuria and mild hyperphenylalaninemia in families with both disorders. N Engl J Med. 1986 May 15;314(20):1276–1280. doi: 10.1056/NEJM198605153142002. [DOI] [PubMed] [Google Scholar]
  23. Nollau P., Wagener C. Methods for detection of point mutations: performance and quality assessment. IFCC Scientific Division, Committee on Molecular Biology Techniques. Clin Chem. 1997 Jul;43(7):1114–1128. [PubMed] [Google Scholar]
  24. Nowacki P. M., Byck S., Prevost L., Scriver C. R. PAH Mutation Analysis Consortium Database: 1997. Prototype for relational locus-specific mutation databases. Nucleic Acids Res. 1998 Jan 1;26(1):220–225. doi: 10.1093/nar/26.1.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Okano Y., Eisensmith R. C., Güttler F., Lichter-Konecki U., Konecki D. S., Trefz F. K., Dasovich M., Wang T., Henriksen K., Lou H. Molecular basis of phenotypic heterogeneity in phenylketonuria. N Engl J Med. 1991 May 2;324(18):1232–1238. doi: 10.1056/NEJM199105023241802. [DOI] [PubMed] [Google Scholar]
  26. Rey F., Abadie V., Lyonnet S., Berthelon M., Caillaud C., Melle D., Labrune P., Saudubray J. M., Munnich A., Rey J. Expression phénotypique de 12 mutations du gène de la phénylalanine hydroxylase. Arch Fr Pediatr. 1992 Oct;49(8):705–710. [PubMed] [Google Scholar]
  27. Richard I., Beckmann J. S. How neutral are synonymous codon mutations? Nat Genet. 1995 Jul;10(3):259–259. doi: 10.1038/ng0795-259. [DOI] [PubMed] [Google Scholar]
  28. Romano V., Guldberg P., Güttler F., Meli C., Mollica F., Pavone L., Giovannini M., Riva E., Biasucci G., Luotti D. PAH deficiency in Italy: correlation of genotype with phenotype in the Sicilian population. J Inherit Metab Dis. 1996;19(1):15–24. doi: 10.1007/BF01799343. [DOI] [PubMed] [Google Scholar]
  29. Savov A., Angelicheva D., Balassopoulou A., Jordanova A., Noussia-Arvanitakis S., Kalaydjieva L. Double mutant alleles: are they rare? Hum Mol Genet. 1995 Jul;4(7):1169–1171. doi: 10.1093/hmg/4.7.1169. [DOI] [PubMed] [Google Scholar]
  30. Svensson E., Eisensmith R. C., Dworniczak B., von Döbeln U., Hagenfeldt L., Horst J., Woo S. L. Two missense mutations causing mild hyperphenylalaninemia associated with DNA haplotype 12. Hum Mutat. 1992;1(2):129–137. doi: 10.1002/humu.1380010208. [DOI] [PubMed] [Google Scholar]
  31. Svensson E., von Döbeln U., Eisensmith R. C., Hagenfeldt L., Woo S. L. Relation between genotype and phenotype in Swedish phenylketonuria and hyperphenylalaninemia patients. Eur J Pediatr. 1993 Feb;152(2):132–139. doi: 10.1007/BF02072490. [DOI] [PubMed] [Google Scholar]
  32. Zschocke J., Graham C. A., Stewart F. J., Carson D. J., Nevin N. C. Non-phenylketonuria hyperphenylalaninaemia in Northern Ireland: frequent mutation allows screening and early diagnosis. Hum Mutat. 1994;4(2):114–118. doi: 10.1002/humu.1380040204. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES